High-throughput organ chip for vascularized tumor organoid culture and preparation method thereof
By using a combination design of bottomless orifice plate and upper chip in microfluidic organ chips, multiple organ chip units are formed using static pressure difference, the flux and cost problems of building vascularized tumor organoid models in the prior art are solved. , and efficient construction of vascularized tumor organoid model and drug screening analysis were achieved.
Patent Information
- Application Number
- CN202411235549.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-12-03
AI Technical Summary
The existing microfluidic organ chips have limitations in hydrogel-stable patterning, chip materials and preparation processes, chip platform flux, etc., making it difficult to effectively build a high-throughput vascularized tumor organoid model, limiting the resistance of Advances in cancer drug development and therapy evaluation.
A high-throughput organ chip is designed, using a combination of bottomless orifice plate and upper chip, and multiple organ chip units are formed through multiple pairs of reservoirs and microflower arrays, and the generation of three-dimensional vascular networks is promoted by static pressure difference. And the preparation cost and time are reduced through precision processing of CNC machine tools, and materials such as PMMA are used to improve the accuracy of drug screening analysis.
It achieves stable hydrogel perfusion and uniform fluid stimulation, promotes the formation of a three-dimensional vascularized tumor organoid model, improves the chip's flux and preparation efficiency, reduces costs, and enhances the accuracy of drug screening analysis.
Smart Images

Figure CN119060843A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of microfluidic chips, and in particular to a high-throughput organ chip for culturing vascularized tumor organoids and a preparation method thereof. Background Art
[0002] Cancer is one of the major problems in the global medical field, which seriously threatens people's lives and brings complex and difficult challenges to researchers and clinicians. According to statistics from the World Health Organization (WHO), there will be 20 million new cancer cases and 9.7 million cancer deaths in the world in 2022. However, the efficiency of anticancer drug development is low, and the success rate of clinical trials is less than 5%. Among them, the in vivo and in vitro models currently used have limitations, which hinder the drug development process. Two-dimensional cell culture models do not have the characteristics of in vivo tissue structure and function, and lack the key microenvironment characteristics of the body; while animal models have ethical requirements and species differences. Therefore, more advanced in vitro models need to be developed in the field of tumor research. Organ chips, as a three-dimensional cell culture device, can accurately regulate the on-chip microenvironment to simulate the specific structure and function of human tissues and organs. Tumor organoid models isolated and cultured from human tumors retain the key genes and phenotypes of patient tumors. Therefore, by combining patient-derived tumor organoids with organ chip technology, patient-specific tumor pathology can be reflected, accelerating anticancer drug screening and targeted therapy evaluation in preclinical studies.
[0003] Tumor organoids are extracted from patients and can reflect the heterogeneity within and between human tumors. Compared with animal models, tumor organoids have a short construction cycle and a high modeling success rate. Therefore, tumor organoids can be widely used in anticancer drug development and preclinical efficacy evaluation, playing a significant role in precision medicine and personalized medicine. Tumors in vivo have rich vascularization characteristics. If in vitro tumor organoids lack blood vessels, the organoids will be limited by the lack of nutrients, which will lead to internal necrosis of the organoids. Therefore, various three-dimensional vascularized organ chip technologies provide solutions for the vascular functionalization of tumor organoid models.
[0004] In previous reports, Ryuji Yokokawa et al. wrote an article in PNAS in 2024 titled "Mimickingangiogenic microenvironment of alveolar soft-part sarcoma in a microfluidiccoculture vasculature chip", introducing a vascularized alveolar soft tissue sarcoma chip, demonstrating the signal transduction role of Rab27a and Sytl2 in the process of tumor angiogenesis. However, the chip was prepared using traditional polydimethylsiloxane (PDMS) soft lithography. The mold is prepared by photolithography, which is costly; and the chip preparation time is long and cumbersome, reducing production efficiency. PDMS material has the characteristics of small molecule adsorption, which is not conducive to immunofluorescence detection and drug screening.
[0005] Noo Li Jeon et al. wrote an article titled "U-IMPACT: a universal 3D microfluidic cell culture platform" in Microsystems & Nanoengineering in 2022, introducing a universal organ chip by injection molding that can construct a tumor cell-induced angiogenesis model. The hydrogel is patterned by spontaneous capillary flow and the principle of capillary burst valve. However, the chip material properties and chip structure need to be precisely designed, otherwise there is a possibility of uneven hydrogel patterning or leakage, which requires high overall chip design. In addition, the mold cost of the injection molding process is high, which will cause a lot of waste of funds, especially in chip prototype design.
[0006] Christopher CWHughes et al. wrote an article in Lab on a Chip in 2017 titled “Avascularized and perfused organ-on-a-chip platform for large-scale drug screening applications”, introducing a high-throughput organ chip platform combined with a standard 96-well plate, integrating 12 chips on a single platform. Among them, a vascularized micro-tumor model was constructed using the angiogenesis mechanism, and anti-angiogenesis and anti-cancer drugs were successfully blindly screened. Among them, the pressure regulation module and the coupled fluid channel greatly increased the complexity of chip design and manufacturing, and reduced the throughput of the overall chip platform.
[0007] The Chinese invention patent with application publication number CN117305223A discloses a method for constructing a vascularized placenta organoid model based on an organ chip. The plug-in organ chip includes an upper cover, a plug-in and a chip body, and the upper cover covers the top of the chip body; the chip body is provided with a through-hole layer and a channel layer from top to bottom, and the channel layer is provided below the corresponding through-hole layer, and the through-hole layer and the channel layer are integrally formed; at least one row of through holes is provided on the through-hole layer, and each row of through holes includes at least 3 through holes, and the through holes are independent of each other and arranged perpendicular to the channel layer, and each row of through holes is used as a culture unit; a plurality of channel slots are provided on the channel layer, and each channel slot corresponds to a culture unit; after the channel layer and the through-hole layer are closed, the bottom of each culture unit is closed around the channel slot, so that each culture unit is an independent structure. Among them, the larger plug-in leads to a lower overall throughput of the chip and a higher sample consumption.
[0008] In summary, the currently reported microfluidic organ chips have certain limitations in terms of stable hydrogel patterning, chip materials and preparation processes, and chip platform throughput. There is an urgent need for a new high-throughput organ chip platform for vascularized tumor organoid culture to assist in the development of anti-cancer drugs and the evaluation of anti-cancer therapies. Summary of the invention
[0009] In view of the defects in the prior art, the object of the present invention is to provide a high-throughput organ chip for culturing vascularized tumor organoids and a preparation method.
[0010] According to one aspect of the present invention, a high-throughput organ chip for vascularized tumor organoid culture is provided, wherein the high-throughput organ chip comprises from top to bottom:
[0011] A bottomless orifice plate, on which a plurality of pairs of liquid storage tanks are arranged, each pair of liquid storage tanks comprising a first liquid storage tank and a second liquid storage tank;
[0012] An upper chip, the upper chip is tightly attached to the bottom of the bottomless well plate; the upper chip is provided with a microfluidic channel array, each microfluidic channel is provided with a first through hole and a second through hole at both ends, the microfluidic channel is connected with the first liquid reservoir through the first through hole, and is connected with the second liquid reservoir through the second through hole, thereby forming a plurality of organ chip units;
[0013] A substrate, the substrate is tightly attached to the bottom of the upper chip;
[0014] A hydrogel mixed with cells and tumor organoids is injected into the first through hole or the second through hole, and cell culture medium of different heights is added to the first liquid reservoir and the second liquid reservoir. The cells in the hydrogel are fluidically stimulated by the static pressure difference to promote the generation of a three-dimensional vascular network.
[0015] Optionally, the bottomless well plate adopts a 96-well or 384-well standard well plate.
[0016] Optionally, a standard well plate cover is provided on the top of the bottomless well plate, and the standard well plate cover is used to prevent the culture medium from volatilizing and being contaminated.
[0017] Optionally, the upper chip is made of any one of polymethyl methacrylate, polycarbonate, polystyrene and cycloolefin copolymer, and the upper chip is precisely machined by a CNC machine tool.
[0018] Optionally, the first through hole and the second through hole are circular through holes with a diameter of 0.5-1 mm.
[0019] Optionally, the microchannel has a height of 100-300 μm and a length of 7-9 mm.
[0020] Optionally, the upper chip is bonded to the bottomless well plate by biocompatible glue.
[0021] Optionally, the substrate is a transparent pressure-sensitive film, and the material of the substrate is polycarbonate or polyethylene terephthalate.
[0022] Optionally, the substrate has a thickness of 100-200 μm.
[0023] According to another aspect of the present invention, a method for preparing the high-throughput organ chip for vascularized tumor organoid culture is provided, the method comprising:
[0024] The upper chip is obtained by precision machining using CNC machine tools;
[0025] Providing a bottomless well plate, ultrasonically cleaning the bottomless well plate and the upper chip, and drying;
[0026] Providing a substrate, and bonding the substrate to the upper chip;
[0027] A layer of biocompatible glue is evenly coated on the bottom of the bottomless well plate, and aligned and bonded to the upper chip to obtain a high-throughput organ chip for vascularized tumor organoid culture.
[0028] Compared with the prior art, the present invention has at least one of the following beneficial effects:
[0029] 1. The present invention uses multiple pairs of reservoirs on a bottomless plate and a microfluidic array on an upper chip. The microfluidic channel is connected to the first reservoir through a first through hole and to the second reservoir through a second through hole to form multiple organ chip units, thereby realizing a high-throughput design. The high-throughput chip can be used to construct a three-dimensional vascular tumor microtissue mimicking the human body in vitro, and a hydrogel mixed with endothelial cells, fibroblasts and tumor organoids is perfused from the through hole to the microfluidic channel to form a three-dimensional capillary network through angiogenesis mechanism; the three-dimensional capillary network spontaneously surrounds the tumor organoid. Since a single organ chip adopts a single microfluidic design, the possibility of hydrogel leakage to other channels is avoided. Furthermore, culture media of different heights are added from the first reservoir and the second reservoir, and the cell culture medium flows into the hydrogel from the through hole to achieve fluid stimulation that meets the requirements of the physiological range and promote the generation of a vascular network. Therefore, the high-throughput organ chip of the present invention can achieve stable hydrogel perfusion, and achieve uniform fluid stimulation through static pressure difference, thereby promoting the formation of a three-dimensional vascularized tumor organoid model.
[0030] 2. The chip preparation method provided by the present invention can greatly reduce the processing time cycle and economic cost by precision machining of the upper chip through CNC numerical control machine tools. The preparation method is simple and effective, fast to build, and low in cost. In addition, the present invention uses PMMA and other materials to make the upper chip. Compared with the PDMS material chip in the prior art, PMMA and other materials do not absorb small molecules, which is helpful for quantitative drug screening analysis. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Other features, objects and advantages of the present invention will become more apparent from the detailed description of non-limiting embodiments made with reference to the following drawings:
[0032] Figure 1 This is an exploded view of a high-throughput organ chip (standard 96-well plate format) for vascularized tumor organoid culture in one embodiment of the present invention;
[0033] Figure 2 Schematic diagram of the structure of a high-throughput organ chip (standard 96-well plate format) for vascularized tumor organoid culture in one embodiment of the present invention;
[0034] Figure 3 Schematic top view of a high-throughput organ chip (standard 96-well plate format) for culturing vascularized tumor organoids in one embodiment of the present invention;
[0035] Figure 4 Schematic side view of a high-throughput organ chip (standard 96-well plate format) for vascularized tumor organoid culture in one embodiment of the present invention;
[0036] Figure 5The fluorescence results of the vascular network on days 0, 3, and 5 of culture using a high-throughput organ chip unit (standard 96-well plate format) in one embodiment of the present invention;
[0037] Figure 6 This is the fluorescence result of the vascular network after 10 times magnification on the 5th day of culture using a high-throughput organ chip unit (standard 96-well plate format) in one embodiment of the present invention;
[0038] Figure 7 The tissue fluorescence results of three-dimensional vascularized tumor organoid culture on days 0, 3, and 5 using a high-throughput organ chip unit (standard 96-well plate format) in one embodiment of the present invention;
[0039] Figure 8 This is an exploded view of a high-throughput organ chip (standard 384-well plate format) for culturing vascularized tumor organoids in one embodiment of the present invention;
[0040] Fig. 9 Schematic diagram of the structure of a high-throughput organ chip (standard 384-well plate format) for vascularized tumor organoid culture in one embodiment of the present invention;
[0041] Fig.10 (a) a schematic side view and (b) a schematic side view of a high-throughput organ chip for vascularized tumor organoid culture in one embodiment of the present invention;
[0042] Fig.11 This is the vascular network structure on days 0, 3, and 5 of culture using high-throughput organ chip units in one embodiment of the present invention.
[0043] The marks in the figure are respectively represented as follows: 1 is a bottomless well plate, 2 is an upper chip, 3 is a substrate, 11 is a first liquid reservoir, 12 is a second liquid reservoir, 21 is a first through hole, 22 is a second through hole, and 23 is a microfluidic channel. DETAILED DESCRIPTION
[0044] The present invention is described in detail below in conjunction with specific embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but are not intended to limit the present invention in any form. It should be noted that, for those of ordinary skill in the art, several variations and improvements may be made without departing from the concept of the present invention. These all belong to the protection scope of the present invention.
[0045] It should be noted that the terms "first", "second", etc. in this application are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the data used in this way can be interchanged where appropriate, so that the embodiments of the invention described herein can be implemented in an order other than those illustrated or described herein. In addition, in this article, the directional words such as front, back, upper, and lower involved are defined by the positions of the parts in the drawings and the positions of the parts relative to each other, just for the clarity and convenience of expressing the technical solution. It should be understood that the use of the directional words should not limit the scope of protection claimed in this application.
[0046] One embodiment of the present invention provides a high-throughput organ chip for vascularized tumor organoid culture, referring to Figure 1-Figure 4 The high-throughput organ chip includes a bottomless well plate 1, an upper chip 2 and a substrate 3 from top to bottom, wherein: a plurality of pairs of liquid reservoirs are provided on the bottomless well plate 1, each pair of liquid reservoirs includes a first liquid reservoir 11 and a second liquid reservoir 12; the upper chip 2 is tightly fitted to the bottom of the bottomless well plate 1; the upper chip 2 is provided with a microfluidic channel array, and the microfluidic channel 23 serves as a tissue chamber. The microfluidic channel 23 is connected to the bottomless well plate 1 through a through hole. Specifically, a first through hole 21 and a second through hole 22 are respectively provided at both ends of each microfluidic channel 23. The microfluidic channel 23 is connected to the first liquid reservoir 11 through the first through hole 21, and is connected to the second liquid reservoir 12 through the second through hole 22, thereby forming a plurality of organ chip units; the substrate 3 is tightly fitted to the bottom of the upper chip 2; first, the through hole is used as a glue injection port, and a hydrogel mixed with cells is injected into the microfluidic channel 23, and then the through hole is used as a culture medium injection port, and the culture medium is added through the liquid reservoir for fluid perfusion. Specifically, a hydrogel mixed with cells and tumor organoids is injected into the microchannel 23 through the first through hole 21 or the second through hole 22. After the hydrogel is solidified, cell culture medium of different heights is added to the first liquid reservoir 11 and the second liquid reservoir 12. The cell culture medium flows into the hydrogel from the first through hole 21 and the second through hole 22. The static pressure difference is used to perform fluid stimulation on the cells in the hydrogel, thereby promoting the generation of a three-dimensional vascular network.
[0047] In the embodiment of the present invention, through multiple pairs of reservoirs on the bottomless well plate 1 and the microfluidic array on the upper chip 2, the microfluidic channel 23 is connected to the first reservoir 11 through the first through hole 21, and is connected to the second reservoir 12 through the second through hole 22, forming multiple organ chip units, thereby realizing high-throughput design. The high-throughput chip can be used to construct human-like three-dimensional vascular tumor microtissues in vitro, and a hydrogel mixed with endothelial cells, fibroblasts and tumor organoids is perfused into the microfluidic channel 23 from the first through hole 21 or the second through hole 22, and a three-dimensional capillary network is formed through the angiogenesis mechanism; the three-dimensional capillary network spontaneously surrounds the tumor organoid. Since a single organ chip adopts a single microfluidic design, the possibility of hydrogel leaking to other channels is avoided. Further, culture medium of different heights is added from the first reservoir 11 and the second reservoir 12, and the culture medium flows into the hydrogel from the first through hole 21 and the second through hole 22, so as to realize fluid stimulation that meets the requirements of the physiological range and promote the generation of vascular networks. Therefore, the high-throughput organ chip in the embodiment of the present invention can achieve stable hydrogel perfusion and uniform fluid stimulation through static pressure difference, thereby promoting the formation of a three-dimensional vascularized tumor organoid model. Compared with the organ chip using plug-ins in the prior art, the organ chip of this application consumes less sample and has a higher throughput at the same chip size, which is more conducive to the high-throughput design of the chip.
[0048] In some embodiments, the bottomless well plate 1 is a 96-well or 384-well standard well plate, respectively. Figure 1 and Figure 8 As shown, the number of microchannels 23 in the corresponding upper chip 2 is 48 and 128, respectively, to achieve high-throughput design of the chip. The upper chip 2 is combined with a standard 96- or 384-well plate and is compatible with commercial sample loading equipment and detectors (such as an ELISA reader, a high-content imaging system, etc.).
[0049] Preferably, a standard well plate cover is provided on the top of the bottomless well plate 1, and the standard well plate cover is used to prevent the culture medium from volatilizing and being contaminated.
[0050] The upper chip 2 requires the use of a high molecular polymer with high optical transparency, high biocompatibility and low small molecule adsorption, such as polymethyl methacrylate (PMMA), polycarbonate (PC), polystyrene (PS), cyclic olefin copolymer (COC or COP), etc. In some embodiments, the material of the upper chip 2 is PMMA, and the upper chip 2 is precisely processed by a CNC machine tool, which can greatly reduce the processing time cycle and economic cost. At the same time, compared with PDMS materials, materials such as PMMA do not absorb small molecules, which is helpful for quantitative drug screening analysis.
[0051] In some embodiments, the first through hole 21 and the second through hole 22 are circular through holes with a diameter of 0.5-1 mm, so as to facilitate the close insertion of a pipette tip to inject the hydrogel.
[0052] In some embodiments, the microchannel 23 has a height of 100-300 μm and a length of 7-9 mm.
[0053] Preferably, the thickness of the upper chip 2 is 2 mm, and the microchannel 23 is arranged in a linear rectangular shape. To match the size of a standard 96-well plate, the row spacing of the microchannel 23 is 9 mm, and the column spacing is 18 mm; to match the size of a standard 384-well plate, the row spacing of the microchannel 23 is 4.5 mm, and the column spacing is 13.5 mm. The microchannel 23 has a width of 1 mm, a height of 300 μm, and a length of 7 mm, ensuring that there is a suitable intercellular flow velocity in the tissue chamber to promote the formation of a three-dimensional vascular network and to be able to inoculate tumor organoids of appropriate size.
[0054] In the above-mentioned embodiment of the present invention, the size, shape and array number of the microchannels of the upper chip 2 can be flexibly designed according to different applications without redesigning the bottomless well plate 1 and the lower substrate 3 .
[0055] In some embodiments, the upper chip 2 is bonded to the bottomless well plate 1 by biocompatible glue. For example, the biocompatible glue can be made of natural polymer materials such as gelatin, sodium alginate, chitosan, or synthetic polymer materials such as polyurethane, polyvinyl alcohol, and polyacrylate. It can also be made of bioactive materials such as growth factors. The biocompatible glue forms a thin layer at the bottom of the bottomless well plate 1 to prevent the glue from clogging the first through hole 21 and the second through hole 22.
[0056] The lower substrate 3 is bonded to the bottom of the upper chip 2 to seal the upper chip 2 to form a closed microchannel. In some embodiments, the substrate 3 is a transparent polycarbonate (PC) or polyethylene terephthalate (PET) pressure-sensitive film. The pressure-sensitive film is selected as the lower substrate for easy tearing, so that the cells cultured in the microchannel 23 can be conveniently removed for subsequent observation and analysis.
[0057] In some embodiments, the thickness of the substrate 3 is 100-200 μm, and the ultra-thin substrate meets the requirements of the confocal microscopy imaging system, ensuring that the cells in the microchannel 23 can be clearly imaged.
[0058] Another embodiment of the present invention provides a method for preparing the high-throughput organ chip for vascularized tumor organoid culture as described above, and further referring to Figure 1-Figure 4 , the method comprising:
[0059] S1, using CNC machine tools to precisely process to obtain the upper chip 2;
[0060] S2, providing a bottomless hole plate 1, immersing the bottomless hole plate 1 and the upper chip 2 in deionized water for ultrasonic cleaning, and drying the cleaned bottomless hole plate 1 and the upper chip 2;
[0061] S3, providing a substrate 3, and bonding the substrate 3 to the upper chip 2;
[0062] S4. Evenly coat the bottom of the bottomless well plate 1 with a layer of biocompatible glue, and align and bond it to the upper chip 2 to obtain a high-throughput organ chip for vascularized tumor organoid culture.
[0063] The specific implementation of each step of the method for preparing a high-throughput organ chip in the embodiment of the present invention can be found in the above-mentioned high-throughput organ chip embodiment, and will not be elaborated in detail here.
[0064] In the chip preparation method in the above embodiment of the present invention, the upper chip is precisely processed by a CNC machine tool, which can greatly reduce the processing time cycle and economic cost. The preparation method is simple and effective, and the construction is fast and the cost is low. In addition, the embodiment of the present invention uses PMMA and other materials to make the upper chip. Compared with the chip made of PDMS material in the prior art, PMMA and other materials do not absorb small molecules, which is helpful for quantitative drug screening analysis.
[0065] The following is explained in conjunction with specific embodiments and application examples. If no specific technology or conditions are specified in each embodiment and application example, the technology or conditions described in the literature in the field or the product instructions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be obtained through commercial channels.
[0066] Example 1
[0067] Reference Figure 1-Figure 4 As shown, it is a schematic diagram of the structure of a high-throughput organ chip for vascularized tumor organoid culture in a standard 96-well plate in this embodiment, and the chip includes, from top to bottom, a bottomless well plate 1, an upper chip 2, and a substrate 3. The bottomless well plate 1 is a standard 96-well bottomless well plate, and the standard 96-well bottomless well plate is provided with an 8*12 liquid reservoir array, which corresponds to 8*6 chip units respectively.
[0068] Reference Figure 4 For a single chip unit, the standard 96 bottomless well plate is provided with a first reservoir 11 and a second reservoir 12, which correspond to the first through hole 21 and the second through hole 22 of the upper chip 2, respectively, so that the microchannel 23 is connected with the first reservoir 11 and the second reservoir 12. Hydrogel mixed with cells can be injected into the microchannel 23 through the first through hole 21 or the second through hole 22 to achieve three-dimensional cell culture. Culture media of different heights are added to the first reservoir 11 and the second reservoir 12, and nutrition supply and fluid stimulation of cells in the hydrogel are achieved through static pressure difference.
[0069] In this embodiment, based on the PMMA material with high biocompatibility, the first through hole 21 and the second through hole 22 for sample addition and the microfluidic channel 23 for tissue culture are CNC-processed, and a pressure-sensitive film can be used as a base 3 for sealing. The bottomless well plate 1 and the upper chip 2 are bonded with biocompatible glue to construct a chip platform with high throughput characteristics.
[0070] In this embodiment, the high-throughput organ chip platform for vascularized tumor organoid culture can be prepared by the following method, including the following steps:
[0071] S1. According to the design of the upper chip 2, the microchannel is precisely processed by a CNC machine tool. The microchannel has a height of 300 μm and a length of 7 mm. The diameters of the first through hole 21 and the second through hole 22 are 1 mm.
[0072] S2. Soak the standard 96-well bottomless plate and the upper chip 2 in deionized water for ultrasonic cleaning, and dry the cleaned standard 96-well bottomless plate and the upper chip 2 at 70°C.
[0073] S3. Use a pressure-sensitive film as a substrate 3 to seal the upper chip 2; press the substrate 3 tightly until there are no bubbles to prevent leakage during subsequent cell culture.
[0074] S4. Prepare a glass plate that matches the size of a standard 96-well plate, evenly coat it with a layer of biocompatible glue, place the standard 96-well plate on it and separate it, so that the bottom of the standard 96-well plate is coated with a layer of biocompatible glue, and finally align and bond it with the upper chip 2. For a single organ chip unit, the first through hole 21 corresponds to the first liquid reservoir 11, and the second through hole 22 corresponds to the second liquid reservoir 12.
[0075] Place the prepared high-throughput organ chip platform in a safety cabinet for UV sterilization for later use.
[0076] For the construction of vascularization model, the co-culture of umbilical vein endothelial cells (HUVEC) and lung fibroblasts (NHLF) can achieve the construction of three-dimensional vascularization model. Figure 5 and Figure 6 , the fibrin gel mixed with HUVEC and NHLF is injected into the microchannel 23 through the first through hole 21. The inoculation concentration of HUVEC and NHLF is 7*10 6 / mL, fibrin gel concentration is 6mg / mL, thrombin concentration is 10U / mL, and gel volume is 10μL. After solidification for 15 minutes, 300μL of EGM-2 medium is added to the first reservoir 11, and 100μL of EGM-2 medium is added to the second reservoir 12. The culture medium is renewed every other day. Under biological and mechanical factors, HUVECs spontaneously connect to form a three-dimensional vascular network after 5 days of culture.
[0077] For the construction of vascularized tumor organoid models, the co-culture of HUVEC, NHLF and tumor organoids can achieve the construction of three-dimensional vascularized tumor organoid models, such as Figure 7 As shown. First, a cell sphere mixed with human liver cancer cells HepG2 and NHLF was prepared using a low-adhesion 96-well plate, where the number of HepG2 and NHLF cells was 500 respectively. Fibrin gel mixed with HUVEC, NHLF and tumor spheres was injected into the microchannel 23 through the first through hole 21. After solidification for 15 minutes, 300 μL of EGM-2 culture medium was added to the first reservoir 11, and 100 μL of EGM-2 culture medium was added to the second reservoir 12. The culture medium was renewed every other day. Under biological and mechanical factors, HUVEC spontaneously connected to form a three-dimensional vascular network after 5 days of culture, and surrounded the tumor spheres.
[0078] Example 2
[0079] This embodiment provides a high-throughput organ chip preparation for vascularized tumor organoid culture based on a standard 384-well plate. The bottomless well plate 1 is a standard 384-well plate, corresponding to 128 organ chip units. Figure 8-Figure 10 The method for preparing a high-throughput organ chip in this embodiment includes the following steps:
[0080] S8. Use Solidworks software to design and use CNC machine tools to precisely process the upper chip 2. The microchannel has a height of 300 μm, a length of 9 mm, a width of 1.5 mm, and a diameter of 1 mm for the first through hole 21 and the second through hole 22.
[0081] S2, immersing the standard 384 bottomless well plate and the upper chip 2 in deionized water for ultrasonic cleaning, and drying the cleaned standard 384 bottomless well plate and the upper chip 2 for later use.
[0082] S3. Use a pressure-sensitive film as the base 3 to seal to the bottom of the upper chip 2, and carefully check the sealing to ensure that there are no bubbles to prevent leakage during subsequent cell culture.
[0083] S4. Prepare a glass plate that matches the size of a standard 384 bottomless well plate, evenly apply a layer of biocompatible glue on it, place the standard 384 bottomless well plate on it and split it apart so that the bottom of the standard 384 bottomless well plate is coated with a layer of biocompatible glue, carefully check whether each area on the bottom of the bottomless well plate is coated with glue, and use a needle to dip into the glue to fill the vacant areas, and finally align and bond it with the upper chip 2.
[0084] Place the prepared high-throughput organ chip platform in a safety cabinet for UV sterilization for later use.
[0085] For vascularization model construction, refer to Fig.11 , the fibrin gel mixed with HUVEC and NHLF is injected into the microchannel 23 through the first through hole 21. The inoculation concentration of HUVEC and NHLF is 7*10 6 / mL, fibrin gel concentration is 6mg / mL, thrombin concentration is 10U / mL, and gel volume is 10μL. After solidification for 15 minutes, 150μL of EGM-2 medium is added to the first reservoir 11, and 50μL of EGM-2 medium is added to the second reservoir 12. The culture medium is renewed every other day. Under biological and mechanical factors, HUVECs spontaneously connect to form a three-dimensional vascular network after 5 days of culture.
[0086] In the above embodiment of the present invention, a high-throughput organ chip is prepared by CNC processing and bonding methods, which has a simple process and overcomes the shortcomings of high cost and long cycle of the current preparation of vascularized tumor organ chips. The single microfluidic channel design facilitates hydrogel inoculation and avoids possible leakage. Combined with bottomless well plates such as standard 96 or 384-well plates, the organ chip of the above embodiment of the present invention is compatible with commercial sample loading equipment and detectors (such as microplate readers, high-content imaging systems). The small molecule adsorption of materials such as PMMA used to make the upper chip is weak, which is conducive to molecular detection and drug screening. The high-throughput organ chip in the above embodiment provides innovative application value in the field of biomedical engineering, especially for the construction of in vitro vascularized tumor disease models and related research on the screening of new anti-tumor drugs.
[0087] The above describes the specific embodiments of the present invention. It should be understood that the present invention is not limited to the above specific embodiments, and those skilled in the art can make various modifications or variations within the scope of the claims, which does not affect the essence of the present invention. The above preferred features can be used in any combination without conflicting with each other.
Claims
1. A high-throughput organ chip for vascularized tumor organoid culture, characterized in that: From top to bottom, it includes: A bottomless orifice plate, on which a plurality of pairs of liquid storage tanks are arranged, each pair of liquid storage tanks comprising a first liquid storage tank and a second liquid storage tank; An upper chip, the upper chip is tightly attached to the bottom of the bottomless well plate; the upper chip is provided with a microfluidic channel array, each microfluidic channel is provided with a first through hole and a second through hole at both ends, the microfluidic channel is connected with the first liquid reservoir through the first through hole, and is connected with the second liquid reservoir through the second through hole, thereby forming a plurality of organ chip units; A substrate, the substrate is tightly attached to the bottom of the upper chip; A hydrogel mixed with cells and tumor organoids is injected into the first through hole or the second through hole, and cell culture medium of different heights is added to the first liquid reservoir and the second liquid reservoir. The cells in the hydrogel are fluidically stimulated by the static pressure difference to promote the generation of a three-dimensional vascular network.
2. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The bottomless well plate adopts a 96-well or 384-well standard well plate.
3. The high-throughput organ chip for vascularized tumor organoid culture according to claim 2, characterized in that: A standard well plate cover is provided on the top of the bottomless well plate, and the standard well plate cover is used to prevent the volatilization and contamination of the culture medium.
4. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The material of the upper chip is any one of polymethyl methacrylate, polycarbonate, polystyrene and cycloolefin copolymer, and the upper chip is precisely processed by a CNC machine tool.
5. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The first through hole and the second through hole are circular through holes with a diameter of 0.5-1 mm.
6. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The microchannel has a height of 100-300 μm and a length of 7-9 mm.
7. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The upper chip is bonded to the bottomless well plate by biocompatible glue.
8. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The substrate is a transparent pressure-sensitive film, and the material of the substrate is polycarbonate or polyethylene terephthalate.
9. The high-throughput organ chip for vascularized tumor organoid culture according to claim 1, characterized in that: The thickness of the substrate is 100-200 μm.
10. A method for preparing a high-throughput organ chip for vascularized tumor organoid culture according to any one of claims 1 to 9, characterized in that: include: The upper chip is obtained by precision machining using CNC machine tools; Providing a bottomless well plate, ultrasonically cleaning the bottomless well plate and the upper chip, and drying them; Providing a substrate, and bonding the substrate to the upper chip; A layer of biocompatible glue is evenly coated on the bottom of the bottomless well plate, and aligned and bonded to the upper chip to obtain a high-throughput organ chip for vascularized tumor organoid culture.
Citation Information
Patent Citations
Organoid perfusion culture chip and application method thereof
CN111548939A
Vascularized tumor microfluidic organ chip used for culture in vitro, and preparation method for vascularized tumor microfluidic organ chip
CN112143642A
Organ model construction method based on organ chip, and organ model
CN112680348A
Devices and methods for vascularizing cell aggregates
CN117157147A
Multifunctional micro-fluidic heart organ chip for in-vitro culture and preparation method thereof
CN117327581A
